Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis

Ola Yaktia Pharmacy Department, Hamad General Hospital, Hamad Medical Corporation, Doha, QatarView further author information

Daoud Al-Badriyehb College of Pharmacy, QU Health, Qatar University, Doha, Qatar

Mohammed Rijimsc Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarView further author information

Mohammed Abdelaald Pharmacy and Drug Control, Ministry of Public Health, Doha, QatarView further author information

Omar Alsoukhnie Pharmacy Department, Al Jalila Children's Specialty Hospital, Dubai, United Arab EmiratesView further author information

Moza Al Hailc Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarView further author information

Palli Valapila Abdulroufc Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarView further author information

Wessam El-Kassemc Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarView further author information

Fouad Abounahiaf Neonatal Intensive Care Unit, Hamad Medical Corporation, Doha, QatarView further author information

Rasha Kaddourag Pharmacy Department, Heart Hospital, Hamad Medical Corporation, Doha, QatarView further author information

Dina Abushanabc Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]

Your download is now in progress and you may close this window